New skin patch SFG-02 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new medicated skin patch called SFG-02 in 32 healthy Japanese and White adults aged 18 to 45. The goal was to see if the patch is safe and how the body absorbs and processes the drug. No treatment was given for any disease, so the study only gather…
Phase: PHASE1 • Sponsor: Juro Sciences Inc. • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC